MedTrace Logo

Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome

NCT02094352 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2018-01-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether epidural and ketamine infusions are effective in the treatment of Complex Regional Pain Syndrome (CRPS).

Conditions

  • Complex Regional Pain Syndrome

Interventions

DRUG

Ketamine Infusion + Epidural Infusion

The ketamine and epidural infusions will be administered over 96 hours with appropriate titration.

DRUG

Control Group + Epidural infusion

The saline and epidural infusions will be administered over 96 hours with appropriate titration.

DRUG

Ketamine Booster Infusion

Patients will receive three ketamine booster infusions over the course of three months.

DRUG

Control Group Booster Infusion

Patients will receive three saline booster infusions over the course of three months.

Sponsors & Collaborators

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Daniel I Richman, MD · Hospital for Special Surgery, New York

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-24
Primary Completion
2015-04-20
Completion
2015-04-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094352 on ClinicalTrials.gov